Table 2.
Variables | Event-Free Survival | Overall Survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
Univariate Analysis | ||||||
FXIII-A expression pattern | ||||||
FXIII-A dim | 0.24 | 0.09–0.64 | 0.004 | 0.32 | 0.09–1.04 | 0.057 |
FXIII-A bright | 4.10 | 1.56–10.78 | 3.17 | 0.97–10.38 | ||
Age | ||||||
1–5 years | 0.52 | 0.19–1.37 | 0.186 | 0.32 | 0.10–1.05 | 0.060 |
≥6 years | 1.92 | 0.73–5.06 | 3.13 | 0.96–10.28 | ||
WBC | ||||||
<20,000 | 0.67 | 0.26–1.76 | 0.417 | 0.56 | 0.17–1.84 | 0.341 |
≥20,000 | 1.49 | 0.57–3.92 | 1.78 | 0.54–5.83 | ||
Sex | ||||||
Male | 1.43 | 0.53–3.86 | 0.483 | 2.08 | 0.55–7.86 | 0.278 |
Female | 0.70 | 0.26–1.90 | 0.48 | 0.18–1.81 | ||
prednisone response | ||||||
PGR | 0.34 | 0.08–1.47 | 0.146 | 0.43 | 0.06–3.41 | 0.427 |
PPR | 1.43 | 0.53–3.86 | 2.08 | 0.55–7.86 | ||
FC risk categories | ||||||
FLR/FMR | 0.90 | 0.27–2.83 | 0.857 | 1.33 | 0.24–5.54 | 0.863 |
FLR/FHR | 1.25 | 0.23–6.81 | 0.801 | 2,59 | 0.36–18.43 | 0.342 |
ALLIC BFM 2009 classification | ||||||
BFM-HR/BFM-SR | 0.39 | 0.098–1.59 | 0.192 | 0.17 | 0.02–1.49 | 0.110 |
BFM-HR/BFM-IR | 0.27 | 0.09–0.78 | 0.015 | 0.21 | 0.06–0.73 | 0.014 |
Genetic risk categories | ||||||
good/intermediate | 2.08 | 0.75–5.74 | 0.051 | 3.68 | 0.92–14.73 | 0.065 |
good/high | 4.86 | 0.99–23.76 | 0.157 | 9.65 | 1.59–58.42 | 0.014 |
B-other | ||||||
Recurrent genetic abnormalities | 0.55 | 0.21–1.44 | 0.225 | 0.41 | 0.12–1.33 | 0.137 |
B-other | 1.80 | 0.70–4.78 | 2.46 | 0.75–8.07 | ||
Multivariate Analysis | ||||||
FXIII-A bright | 3.92 | 1.41–10.84 | 0.009 | 3.90 | 0.99–15.31 | 0.051 |
Genetic risk categories | ||||||
good/intermediate | 2.69 | 0.84–8.55 | 0.095 | 6.07 | 1.17–31.65 | 0.032 |
good/high | 3.56 | 0.70–18.03 | 0.124 | 7.67 | 1.21–48.64 | 0.031 |
p < 0.05 values were considered statistically significant, such p values are marked in bold.